FDA Inspection
Novo Nordisk A/SNovo Nordisk A/S – FDA Inspection, May 4, 2023
Record Details
This FDA Inspection record concerns Novo Nordisk A/S, with an inspection on May 4, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Mikhail V. Ovanesov
- Prabhu P. Raju (FDA Associated Person)
- Unnee Ranjan (FDA Associated Person)
View Company Profile
ID · 66074870-de76-43e2-b8fd-c93d30311f61
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1209127
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Novo Nordisk A/S
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2024 | Not classified | Office of Inspections and Investigations | |
| December 2, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2018 | Not classified | Office of Inspections and Investigations | |
| August 29, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S
- FDA Inspection 1269488 - 2024-03-25
- FDA Inspection 1230597 - 2022-12-02
- FDA Inspection 1107225 - 2019-09-06
- FDA Inspection 1044502 - 2018-03-07
- FDA Inspection 1028554 - 2017-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.